KR101456438B1 - N-(브로모아세틸)-3,3-디니트로아제티딘을 합성 및 분리하는 방법 및 상기 화합물을 포함하는 조성물 - Google Patents

N-(브로모아세틸)-3,3-디니트로아제티딘을 합성 및 분리하는 방법 및 상기 화합물을 포함하는 조성물 Download PDF

Info

Publication number
KR101456438B1
KR101456438B1 KR1020127022598A KR20127022598A KR101456438B1 KR 101456438 B1 KR101456438 B1 KR 101456438B1 KR 1020127022598 A KR1020127022598 A KR 1020127022598A KR 20127022598 A KR20127022598 A KR 20127022598A KR 101456438 B1 KR101456438 B1 KR 101456438B1
Authority
KR
South Korea
Prior art keywords
abdnaz
solvent
dnaz
bromoacetyl
dinitroazetidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127022598A
Other languages
English (en)
Korean (ko)
Other versions
KR20130053385A (ko
Inventor
니콜라스 에이. 스트라에슬러
루이스 에프. 카니조
핑 리
마이클 피. 크레이머
데이비드 엠. 로젠버그
Original Assignee
얼라이언트테크시스템즈인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 얼라이언트테크시스템즈인코포레이티드 filed Critical 얼라이언트테크시스템즈인코포레이티드
Publication of KR20130053385A publication Critical patent/KR20130053385A/ko
Application granted granted Critical
Publication of KR101456438B1 publication Critical patent/KR101456438B1/ko
Assigned to 노스롭 그루만 시스템즈 코퍼레이션 reassignment 노스롭 그루만 시스템즈 코퍼레이션 권리의 전부이전등록 Assignors: 노스롭 그루먼 이노베이션 시스템스 엘엘씨
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020127022598A 2010-02-09 2011-01-18 N-(브로모아세틸)-3,3-디니트로아제티딘을 합성 및 분리하는 방법 및 상기 화합물을 포함하는 조성물 Active KR101456438B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/702,782 US8471041B2 (en) 2010-02-09 2010-02-09 Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US12/702,782 2010-02-09
PCT/US2011/021500 WO2011100090A1 (en) 2010-02-09 2011-01-18 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same

Publications (2)

Publication Number Publication Date
KR20130053385A KR20130053385A (ko) 2013-05-23
KR101456438B1 true KR101456438B1 (ko) 2014-10-31

Family

ID=43875262

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127022598A Active KR101456438B1 (ko) 2010-02-09 2011-01-18 N-(브로모아세틸)-3,3-디니트로아제티딘을 합성 및 분리하는 방법 및 상기 화합물을 포함하는 조성물

Country Status (12)

Country Link
US (1) US8471041B2 (https=)
EP (1) EP2534131B1 (https=)
JP (1) JP5461712B2 (https=)
KR (1) KR101456438B1 (https=)
CN (1) CN102762535B (https=)
AU (1) AU2011216176B2 (https=)
CA (1) CA2788459C (https=)
DK (1) DK2534131T3 (https=)
ES (1) ES2460040T3 (https=)
IL (1) IL221141A (https=)
MX (1) MX2012008989A (https=)
WO (1) WO2011100090A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
CA2850723C (en) 2011-10-07 2019-07-09 Radiorx, Inc. Organonitro thioether compounds and medical uses thereof
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
CN109069420A (zh) 2016-01-11 2018-12-21 埃皮辛特瑞柯斯公司 2-溴-1-(3，3-二硝基氮杂环丁烷-1-基)乙酮静脉施用的组合物和方法
SG11201903312VA (en) 2016-10-14 2019-05-30 Epicentrix Inc Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
EP3648740A1 (en) 2017-07-07 2020-05-13 EpicentRx, Inc. Compositions for parenteral administration of therapeutic agents
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
BR112023025535A2 (pt) 2021-06-09 2024-02-27 Epicentrx Inc Composições de abdnaz cristalinas e métodos para fazer e usar as mesmas
WO2024145484A1 (en) 2022-12-29 2024-07-04 Epicentrx, Inc. Rrx-001 for treating reproductive-related disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090037374A (ko) * 2005-08-12 2009-04-15 앨리언트 테크시스템즈 인코포레이티드 환형 니트로 화합물, 그의 약학적 조성물 및 용도

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60116642A (ja) 1983-11-29 1985-06-24 Nippon Kayaku Co Ltd ２−モノ−置換メチル−５，５−ジメチル−シクロ−２−ヘキセノン誘導体
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
GB8728418D0 (en) 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5693794A (en) 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
JP2659614B2 (ja) 1990-11-13 1997-09-30 株式会社日立製作所 表示制御装置
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5336784A (en) 1993-06-07 1994-08-09 The Regents Of The University Of California Synthesis of 1,3,3-trinitroazetidine
JP3211892B2 (ja) 1994-05-27 2001-09-25 セイジィ ファーマスーティカルス インコーポレーテッド 肛門疾患を治療する窒素酸化物供与体及び方法
US5970974A (en) 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
DE69605025T2 (de) 1995-03-14 2000-07-20 Siemens Ag Ultraschallzerstäuber mit abnehmbarer präzisionsdosiereinheit
WO1996036602A1 (en) 1995-05-15 1996-11-21 The United States Of America Adnaz, compositions and processes
US5580988A (en) 1995-05-15 1996-12-03 The United States Of America As Represented By The Secretary Of The Army Substituted azetidines and processes of using them
US5898038A (en) 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
IL128589A0 (en) 1996-10-15 2000-01-31 Eastman Chem Co Explosive formulations
GB9720797D0 (en) 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6056966A (en) 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
EP1098641B1 (en) 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
US6448253B1 (en) 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6245799B1 (en) 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
PL358623A1 (en) 2000-04-10 2004-08-09 Pfizer Products Inc. Benzoamide piperidine compounds as substance p antagonists
US6861530B2 (en) 2000-07-07 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
DE10111049A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20040167212A1 (en) 2002-10-07 2004-08-26 Bednarski Mark D. X-nitro compounds, pharmaceutical compositions thereof and uses thereof
US6870061B2 (en) 2003-01-10 2005-03-22 Alliant Techsystems Inc. Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
EP1603933A2 (en) 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
ATE500216T1 (de) 2003-06-25 2011-03-15 Je Il Pharmaceutical Co Ltd Tricyclische derivate oder pharmazeutisch unnbedenkliche salze davon, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
EP1791544A4 (en) 2004-09-08 2007-09-12 Chelsea Therapeutics Inc CHINAZOLINE DERIVATIVES AS METABOLIC INERT ANTIFOLATE
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
JP2009510073A (ja) 2005-09-27 2009-03-12 ノバルティス アクチエンゲゼルシャフト カルボキシアミン化合物およびその使用方法
KR100967848B1 (ko) * 2008-05-28 2010-07-05 국방과학연구소 분자화약이 도입된, 고에너지 결합제용1-글리시딜-3,3-디니트로아제티딘 및 그의 제조방법
WO2012078992A1 (en) 2010-12-09 2012-06-14 Radiorx, Inc. Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090037374A (ko) * 2005-08-12 2009-04-15 앨리언트 테크시스템즈 인코포레이티드 환형 니트로 화합물, 그의 약학적 조성물 및 용도

Also Published As

Publication number Publication date
KR20130053385A (ko) 2013-05-23
CA2788459C (en) 2016-01-05
JP5461712B2 (ja) 2014-04-02
AU2011216176A1 (en) 2012-08-23
MX2012008989A (es) 2012-08-23
EP2534131B1 (en) 2014-03-19
EP2534131A1 (en) 2012-12-19
WO2011100090A1 (en) 2011-08-18
ES2460040T3 (es) 2014-05-13
IL221141A0 (en) 2012-09-24
US8471041B2 (en) 2013-06-25
JP2013518925A (ja) 2013-05-23
CA2788459A1 (en) 2011-08-18
DK2534131T3 (da) 2014-04-07
CN102762535A (zh) 2012-10-31
CN102762535B (zh) 2014-09-03
IL221141A (en) 2016-08-31
US20110195947A1 (en) 2011-08-11
AU2011216176B2 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
KR101456438B1 (ko) N-(브로모아세틸)-3,3-디니트로아제티딘을 합성 및 분리하는 방법 및 상기 화합물을 포함하는 조성물
EP3490973B1 (en) Polymorphic forms of belinostat and processes for preparation thereof
EP2238152A2 (en) Solid and crystalline dutasteride and processes for preparation thereof
EP1871750A1 (en) Improved process for the preparation of letrozole
JP5916721B2 (ja) 集中的還元的アミノ化によるフェロキンの合成方法
EP2906530B1 (en) Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
CN111471070B (zh) 瑞德西韦的合成方法
JP6816274B2 (ja) （ｓ）−ｎ１−（２−アミノエチル）−３−（４−アルコキシフェニル）プロパン−１，２−ジアミン三塩酸塩の製造方法
JP2011006379A (ja) ｛２−アミノ−１，４−ジヒドロ−６−メチル−４−（３−ニトロフェニル）−３，５−ピリジンジカルボン酸３−（１−ジフェニルメチルアゼチジン−３−イル）エステル５−イソプロピルエステル｝（アゼルニジピン）の再結晶方法、アゼルニジピンのイソプロピルアルコール付加体、およびアゼルニジピンの製造方法
TWI441811B (zh) 合成經取代異喹啉的方法
JP2001278867A (ja) 環式酸の製造
WO2023100110A1 (en) Process for preparing brivaracetam
JP2019131532A (ja) 酸無水物、および該酸無水物を用いたｌ−カルノシンの製造方法
JP3230723B2 (ja) ２−（フルフリルチオ）酢酸誘導体の製造方法
TW202513046A (zh) 製備１－乙基－Ｎ－（（１，２，３，５，６，７－六氫－ｓ－二環戊二烯并苯－４－基）胺甲醯基）哌啶－４－磺醯胺之製備方法
WO2024033632A1 (en) An improved process for preparing antiviral phosphonate analogues
JP2009501146A (ja) ベンズイミダゾール化合物の調製方法
JP4052786B2 (ja) ２−クロロ−４−（１−ピペリジニルメチル）ピリジンの精製方法
CN120112512A (zh) 制备(z)-3-(2-(5-溴-1h-吲哚-3-基)-2-氰基乙烯基)-4-甲氧基苯甲腈的方法
WO2022079194A1 (en) Process for the production of glycopyrronium tosylate
JP2023032757A (ja) エポキシアミン化合物の製造方法
HK40003591B (en) Polymorphic forms of belinostat and processes for preparation thereof
WO2006059774A1 (ja) ジアリルビスフェノール化合物の精製方法
JP2004217556A (ja) １，３−ジアルキル−２−ベンズイミダゾリノン類の製造法
WO2014125231A1 (fr) Procede de synthese de composes 4-(heterocycloalkyl)-benzene-1,3-diol

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20120829

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140207

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20140207

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140620

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20140923

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20141024

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20141027

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20181012

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20181012

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20211014

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20221013

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20231012

Start annual number: 10

End annual number: 10